Skip navigation

Strategic Forecasting, Accounting Estimates, Analytics and Financial Reporting for Life Science Companies

November 12-14, 2019
  • Philadelphia, PA

The materiality and complexity of gross-to-net within the life sciences sector continues to swell; Proactive and strategic management of GTN is critical. CBI’s longstanding Gross-to-Net Summit is built for biotech, pharma and generic drug companies of all sizes and stages. Whether your organization is pre-commercial revenue or is managing multiple products and large revenue streams, the GTN models and processes shared at the conference are paramount to success and compliance. Attendees consistently walk away with best practices for a well-designed, multi-faceted approach to GTN management for enhanced visibility, profitability and control.

Earn
CPE Credits!
Pending Approval

New This Year!

Attendees choose from two tailored workshops and provided with pre and post workshop take home materials for a GTN playbook.

I. Industry 101 Boot Camp – GTN Process Establishment and Best Practices

II. Senior Executive Master Class – Next-Level Strategies for GTN Optimization

And, choose from multiple in-conference learning labs, discussion groups and tracks of content to customize your learning to your business needs.

Gain Strategies to:

  • Accurately capture, monitor and report GTN data
  • Forecast and plan for GTN liabilities
  • Estimate product returns with little to no historical data
  • Manage GTN for return accruals, new product launches and patent expiries/discontinuation/recalls
  • Report and understand indirect/non-contracted sales
  • Account for coupon, copay and voucher programs
  • Anticipate and substantiate shifts in chargebacks
  • Assess the financial impact of Healthcare reform

GTN 2019

Strategic Forecasting, Accounting Estimates, Analytics and Financial Reporting for Life Science Companies

The materiality and complexity of gross-to-net within the life sciences sector continues to swell; Proactive and strategic management of GTN is critical. CBI’s longstanding Gross-to-Net Summit is built for biotech, pharma and generic drug companies of all sizes and stages. Whether your organization is pre-commercial revenue or is managing multiple products and large revenue streams, the GTN models and processes shared at the conference are paramount to success and compliance. Attendees consistently walk away with best practices for a well-designed, multi-faceted approach to GTN management for enhanced visibility, profitability and control.

Earn
CPE Credits!
Pending Approval

New This Year!

Attendees choose from two tailored workshops and provided with pre and post workshop take home materials for a GTN playbook.

I. Industry 101 Boot Camp – GTN Process Establishment and Best Practices

II. Senior Executive Master Class – Next-Level Strategies for GTN Optimization

And, choose from multiple in-conference learning labs, discussion groups and tracks of content to customize your learning to your business needs.

Gain Strategies to:

  • Accurately capture, monitor and report GTN data
  • Forecast and plan for GTN liabilities
  • Estimate product returns with little to no historical data
  • Manage GTN for return accruals, new product launches and patent expiries/discontinuation/recalls
  • Report and understand indirect/non-contracted sales
  • Account for coupon, copay and voucher programs
  • Anticipate and substantiate shifts in chargebacks
  • Assess the financial impact of Healthcare reform